Developing yeast models of human neurodegenerative disorders

Alejandro Ocampo, Antonio Barrientos

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
Pages113-127
Number of pages15
Volume793
DOIs
StatePublished - Oct 24 2011

Publication series

NameMethods in Molecular Biology
Volume793
ISSN (Print)10643745

Fingerprint

Neurodegenerative Diseases
Yeasts
Saccharomyces cerevisiae
Proteins
Animal Models
Population
Therapeutics
Ectopic Gene Expression

Keywords

  • Neurodegeneration
  • Protein aggregation
  • Proteinophaties
  • Yeast model

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Ocampo, A., & Barrientos, A. (2011). Developing yeast models of human neurodegenerative disorders. In Methods in Molecular Biology (Vol. 793, pp. 113-127). (Methods in Molecular Biology; Vol. 793). https://doi.org/10.1007/978-1-61779-328-8_8

Developing yeast models of human neurodegenerative disorders. / Ocampo, Alejandro; Barrientos, Antonio.

Methods in Molecular Biology. Vol. 793 2011. p. 113-127 (Methods in Molecular Biology; Vol. 793).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ocampo, A & Barrientos, A 2011, Developing yeast models of human neurodegenerative disorders. in Methods in Molecular Biology. vol. 793, Methods in Molecular Biology, vol. 793, pp. 113-127. https://doi.org/10.1007/978-1-61779-328-8_8
Ocampo A, Barrientos A. Developing yeast models of human neurodegenerative disorders. In Methods in Molecular Biology. Vol. 793. 2011. p. 113-127. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-61779-328-8_8
Ocampo, Alejandro ; Barrientos, Antonio. / Developing yeast models of human neurodegenerative disorders. Methods in Molecular Biology. Vol. 793 2011. pp. 113-127 (Methods in Molecular Biology).
@inbook{542da285cd6549419b2604cd0888d775,
title = "Developing yeast models of human neurodegenerative disorders",
abstract = "Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.",
keywords = "Neurodegeneration, Protein aggregation, Proteinophaties, Yeast model",
author = "Alejandro Ocampo and Antonio Barrientos",
year = "2011",
month = "10",
day = "24",
doi = "10.1007/978-1-61779-328-8_8",
language = "English",
isbn = "9781617793271",
volume = "793",
series = "Methods in Molecular Biology",
pages = "113--127",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Developing yeast models of human neurodegenerative disorders

AU - Ocampo, Alejandro

AU - Barrientos, Antonio

PY - 2011/10/24

Y1 - 2011/10/24

N2 - Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.

AB - Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.

KW - Neurodegeneration

KW - Protein aggregation

KW - Proteinophaties

KW - Yeast model

UR - http://www.scopus.com/inward/record.url?scp=80054764778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054764778&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-328-8_8

DO - 10.1007/978-1-61779-328-8_8

M3 - Chapter

SN - 9781617793271

VL - 793

T3 - Methods in Molecular Biology

SP - 113

EP - 127

BT - Methods in Molecular Biology

ER -